Exelixis Inc.’s filing revealed that its EVP, General Counsel & Sec Hessekiel Jeffrey unloaded Company’s shares for reported $1.33 million on Mar 01. In the deal valued at $17.13 per share,77,860 shares were sold. As a result of this transaction, Hessekiel Jeffrey now holds 527,716 shares worth roughly $ 8.87 million.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Then, Aftab Dana sold 82,490 shares, generating $1,443,575 in total proceeds. Upon selling the shares at $17.50, the CSO/EVP Disc & Trans Research now owns 351,472 shares.
Before that, Aftab Dana sold 10 shares. Exelixis Inc. shares valued at $175 were divested by the CSO/EVP Disc & Trans Research at a price of $17.50 per share. As a result of the transaction, Aftab Dana now holds 351,472 shares, worth roughly $5.91 million.
Wells Fargo initiated its Exelixis Inc. [EXEL] rating to an Overweight in a research note published on Monday, March 09, 2023; the price target was $23. PT values the company’s stock at a premium of 26.91 to its Monday closing price. A number of analysts have revised their coverage, including Credit Suisse’s analysts, who began to cover the stock in late January with a ‘”an Outperform”‘ rating. JMP Securities began covering EXEL with “Mkt outperform” recommendation on October 18, 2022. BMO Capital Markets started covering the stock on June 24, 2022. It rated EXEL as “an Outperform”.
Price Performance Review of EXEL
On Monday, Exelixis Inc. [NASDAQ:EXEL] saw its stock jump 0.78% to $16.81. On the same session, the stock had its day’s lowest price of $16.585, but rose to a high of $17.02. Over the last five days, the stock has gained 2.06%. Exelixis Inc. shares have risen nearly 4.80% since the year began. Nevertheless, the stocks have fallen -21.19% over the past one year. While a 52-week high of $23.40 was reached on 02/14/23, a 52-week low of $14.87 was recorded on 01/03/23. SMA at 50 days reached $17.09, while 200 days put it at $17.84. A total of 4.42 million shares were traded, compared to the trading of 5.56 million shares in the previous session.
Levels Of Support And Resistance For EXEL Stock
The 24-hour chart illustrates a support level at 16.59, which if violated will result in even more drops to 16.37. On the upside, there is a resistance level at 17.02. A further resistance level may holdings at 17.24. The Relative Strength Index (RSI) on the 14-day chart is 45.56, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.26, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 56.11%. Stochastics %K at 37.95% indicates the stock is a holding.
How much short interest is there in Exelixis Inc.?
A steep rise in short interest was recorded in Exelixis Inc. stocks on Jan 30, 2023, dropping by -1.09 million shares to a total of 10.51 million shares. Yahoo Finance data shows the prior-month short interest on Dec 29, 2022 was 11.6 million shares. There was a decline of -10.37%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 3.66% of the overall stock float, the days-to-cover ratio (short ratio) fell to 3.49.
Exelixis Inc. [EXEL] – Who Are The Largest Shareholders?
In filings from The Vanguard Group, Inc., it is revealed that the company now owns 31,833,803 shares, or roughly 9.82% of the outstanding EXEL shares. In other words, the investor’s shares have risen by 990,672 from its previous 13-F filing of 30843131.0. Additionally, BlackRock Fund Advisors increased 0.96% of its stake after which the total value it holdings stand at $510,130,512, while Renaissance Technologies LLC reduced -6.67% of its stake to hold $255.54 million in the firm. Over the last quarter, SSgA Funds Management, Inc. purchased 756,068 shares of Exelixis Inc., while Fidelity Management & Research Co bought -2,526,690 shares. At present, Farallon Capital Management LLC is holding 10,868,149 shares valued at $185.63 million. JPMorgan Investment Management, I owned 9,554,714 shares of the company at the time of its most recent 13F filing, worth $163.19 million.
According to FactSet, Exelixis Inc.’s share price will average $25.06 in the next year, based on opinions of analysts polled by the firm. This is up nearly 49.88 percent from its previous closing price of $16.68. Analysts expect Exelixis Inc. stock to reach the higher price of $32.00, while the lowest price estimate is $17.00. However, 19 analysts have rated EXEL stock as an Overweight in their predictions for 2023. The most recent change occurred on November 19, 2021 when Piper Sandler began covering the stock and recommended ‘”an Overweight”‘ rating along with a $34 price target.